1,600
Total number of shares with voting rights that can be issued following the exercise of the attributed warrants, and the conversion of the convertible bonds
804,315
(2)
(1) The total number of attributed warrants has increased by 99,832 warrants granted under the existing warrant plans.
(2)
232,887 shares can be issued in case all 232,887 attributed warrants are exercised.
571,428 shares can be issued in case all 1,600 convertible bonds outstanding, issued in the private placement on 6 May 2020, are converted into shares based on the predetermined conversion price of EUR 7.00.
About Bone Therapeutics
Bone Therapeutics is a leading biotech company focused on the development of innovative products to address high unmet needs in orthopedics and other diseases. The Company has a, diversified portfolio of cell and biologic therapies at different stages ranging from pre-clinical programs in immunomodulation to mid-to-late stage clinical development for orthopedic conditions, targeting markets with large unmet medical needs and limited innovation.